CSIR-NBRI transfer herbal Curcumin technology to Hyderabad firm

 

by IANS |



Lucknow, Oct 26 (IANS) The CSIR-National Botanical Research Institute (NBRI) in Lucknow has transferred the technology for Croma-3, edible capsules of Curcumin, to a Hyderabad-based firm.


Herbal Curcumin is the main active component of turmeric.


“This technology was developed in 2022 and had already been transferred to a company. Now, we are licensing this technology to another Hyderabad-based company named M/s Xavier Med Pvt Ltd for better availability in the market,” said B N Singh, principal scientist, CSIR-NBRI, and the brain behind the Curcumin capsule.


“This herbal formulation contains more than 10 per cent Curcumin, which strengthens the body’s immune system and reduces oxidative stress of the cells. This formulation was developed as per the guidelines of the AYUSH ministry,” he added.


“CSIR-NBRI prepared a formulation with better bioavailability and medicinal properties,” said institute director Ajit Kumar Shasany.



Latest News
IPL 2026: When and Where to watch LSG vs KKR, know all details Sat, Apr 25, 2026, 04:14 PM
Tablet-based cancer treatments emerging as promising alternative to chemotherapy, says Vice President in Jaipur Sat, Apr 25, 2026, 03:27 PM
Haven't seen myself, can't say where it came from: Ex-Army chief on Rahul's claims about unpublished book Sat, Apr 25, 2026, 03:18 PM
India's bio-economy projected to touch $1 trillion by 2047: Minister Sat, Apr 25, 2026, 03:15 PM
Technology is reshaping trading, distribution and advice: SEBI Chairman Sat, Apr 25, 2026, 03:14 PM